These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8152287

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial.
    Rusconi S, De Pasquale MP, Milazzo L, Moscatelli G, Bulgheroni E, Citterio P, d'Arminio-Monforte A, Moroni M, Galli M.
    Antivir Ther; 1997 Jan; 2(1):39-46. PubMed ID: 11322265
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral load.
    Rubio A, Gómez-Cano M, Puig T, Leal M, Pérez-Olmeda M, Ruiz L, Clotet B, Rey C, Zamora L, Xaus N, Soriano V.
    Antivir Ther; 1999 Jan; 4(1):45-9. PubMed ID: 10682128
    [Abstract] [Full Text] [Related]

  • 29. Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds.
    Wondimu Z, Sönnerborg A, Ayehunie S, Britton S, Strannegård O.
    Antiviral Res; 1992 Oct 01; 19(4):353-9. PubMed ID: 1281393
    [Abstract] [Full Text] [Related]

  • 30. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
    Jeeninga RE, Keulen W, Boucher C, Sanders RW, Berkhout B.
    Virology; 2001 May 10; 283(2):294-305. PubMed ID: 11336554
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
    Gurusinghe AD, Land SA, Birch C, McGavin C, Hooker DJ, Tachedjian G, Doherty R, Deacon NJ.
    J Med Virol; 1995 Jul 10; 46(3):238-43. PubMed ID: 7561796
    [Abstract] [Full Text] [Related]

  • 33. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
    Gao Q, Gu ZX, Parniak MA, Li XG, Wainberg MA.
    J Virol; 1992 Jan 10; 66(1):12-9. PubMed ID: 1727474
    [Abstract] [Full Text] [Related]

  • 34. Predominance of codon 215 mutation in reverse transcriptase-coding region of 3'-azido-3'-deoxythymidine (AZT)-resistant HIV-1 isolates after long-term AZT therapy.
    Kondo M.
    Kansenshogaku Zasshi; 1995 Nov 10; 69(11):1278-85. PubMed ID: 8708409
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy.
    Fitzgibbon JE, Howell RM, Schwartzer TA, Gocke DJ, Dubin DT.
    AIDS Res Hum Retroviruses; 1991 Mar 10; 7(3):265-9. PubMed ID: 2064825
    [Abstract] [Full Text] [Related]

  • 37. [Investigation of AZT susceptibility of sequential HIV-1 isolates from patients treated with ddI after long-term therapy with AZT].
    Saito T, Kondo M, Ito A, Nagao T, Hayashi T, Watanabe S, Imai M.
    Kansenshogaku Zasshi; 1994 Jul 10; 68(7):819-23. PubMed ID: 8089546
    [Abstract] [Full Text] [Related]

  • 38. Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.
    Kellam P, Boucher CA, Tijnagel JM, Larder BA.
    J Gen Virol; 1994 Feb 10; 75 ( Pt 2)():341-51. PubMed ID: 7509370
    [Abstract] [Full Text] [Related]

  • 39. Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI.
    Reichman RC, Tejani N, Lambert JL, Strussenberg J, Bonnez W, Blumberg B, Epstein L, Dolin R.
    Antiviral Res; 1993 Apr 10; 20(4):267-77. PubMed ID: 8097906
    [Abstract] [Full Text] [Related]

  • 40. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.
    Tachedjian G, Mellors J, Bazmi H, Birch C, Mills J.
    J Virol; 1996 Oct 10; 70(10):7171-81. PubMed ID: 8794364
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.